China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Platelet‑elevating Effect and Safety of Recombinant Human Thrombopoietin (rhTPO)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130614
Registration Time: 2026/08/21
Type: Interventional study
Primary Sponsor: Tianjin Third Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339149
Published by HT Digital Content Services with permission from Health Daily Digest....